Medicament for treating viral hepatitis

A viral hepatitis and drug technology, applied in the direction of antiviral agents, drug combinations, pharmaceutical formulations, etc., can solve the problem that the specificity of treatment and the diversity of drugs cannot meet the needs of patients with viral hepatitis, and achieve ideal therapeutic effect and recurrence The effect of low rate, improvement or disappearance of hepatitis symptoms

Inactive Publication Date: 2013-05-29
CHENGDU JIANJIANG PHARMA FACTORY
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] But the traditional Chinese medicine of the prior art is far from being able to satisfy the demand of viral hepatitis patient aspect the specificity of treatment and the diversity of medicine.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] The present embodiment is the method for preparing pills.

[0019] Take 10 parts of Radix Isatidis, 8 parts of Folium Isatidis, 8 parts of Honeysuckle, 2 parts of Ginseng, 6 parts of Salvia, 8 parts of Astragalus, 2 parts of Honeysuckle, 2 parts of Panax notoginseng, 3 parts of Fushen, 5 parts of Baiziren, and 5 parts of Asparagus 4 parts, 4 parts of leech, 2 parts of Chuanxiong, 5 parts of Schisandra, 3 parts of licorice, and 3 parts of polygala. Steam in boiling water at 100°C for 60 minutes, spread to cool and then dry in the sun, crush the above raw materials into fine powder and mix evenly, add cinnamon aldehyde, creatinine, vitamin C and coenzyme Q10, etc. Water is mixed and stirred, and cinnabar is used as a coating to make pills.

Embodiment 2

[0021] This embodiment is a method for preparing an aqueous solution.

[0022] Take 15 parts of Radix Isatidis, 12 parts of Folium Isatidis, 10 parts of Honeysuckle, 6 parts of Ginseng, 10 parts of Salvia, 12 parts of Astragalus, 3 parts of Honeysuckle, 4 parts of Panax notoginseng, 6 parts of Fushen, 13 parts of Baiziren, and 13 parts of Asparagus 8 parts of leech, 4 parts of Chuanxiong, 13 parts of Schisandra chinensis, 12 parts of licorice, 6 parts of polygala, and 2 parts of cinnabar.

[0023] Add water that is 5 times the weight of the medicinal materials used and boil it. After boiling on a high fire, change it to a slow fire and boil it for 20 minutes, filter it out, and repeat three times. Mix the three water preparations, add cinnamon aldehyde, creatinine, vitamin C, coenzyme Q10 and honey as appropriate, divide into several parts, and take according to the dosage of ordinary Chinese medicine.

Embodiment 3

[0025] This embodiment is a method for preparing tablets.

[0026] Take 8 parts of Radix Isatidis, 10 parts of Folium Isatidis, 6 parts of Honeysuckle, 4 parts of Ginseng, 8 parts of Salvia, 10 parts of Astragalus, 2 parts of Honeysuckle, 3 parts of Panax notoginseng, 4 parts of Fushen, 7 parts of Baiziren, and 10 parts of Asparagus 7 parts of leech, 3 parts of Chuanxiong, 10 parts of Schisandra chinensis, 10 parts of licorice, 5 parts of polygala, and 1 part of cinnabar. Steam in boiling water at 100°C for 60 minutes, spread to cool and then dry in the sun. Grind the above raw materials into fine powder and mix evenly. Add cinnamon aldehyde, creatinine, vitamin C and coenzyme Q10 as appropriate. Mix evenly and press into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for treating viral hepatitis. The medicament is prepared from the raw materials: 10 to 15 parts of isatis root, 8 to 12 parts of folium isatidis, 6 to 10 parts of honeysuckle stem, 2 to 6 parts of ginseng, 6 to 10 parts of root of red-rooted salvia, 8 to 12 parts of astragalus root, 2 to 3 parts of honeysuckle, 2 to 4 parts of pseudo-ginseng, 3 to 6 parts of fushen, 5 to 13 parts of platycladi seed, 5 to 13 parts of asparagus root, 4 to 8 parts of leech, 2 to 4 parts of Szechuan lovage rhizome, 5 to 13 parts of schisandra, 3 to 12 parts of licorice, 3 to 6 parts of polygala root, 1 to 2 parts of cinnabar and the like which are used as raw materials, creatinine, vitamin C, coenzyme Q10 and the like. The medicament combines Chinese medicine and western medicine, treats both symptoms and root causes, and has the effects of diminishing inflammation, resisting viruses, nourishing liver, nourishing yin, clearing heat, enriching qi and blood, tranquilizing by nourishing the heart, eliminating the pathogen and strengthening the vital qi. After patients administrate the medicament, the treatment effect is ideal, and the viral hepatitis symptom is obviously improved or disappears.

Description

technical field [0001] The invention relates to a medicine for treating hepatitis, in particular to a medicine for treating viral hepatitis. Background technique [0002] Viral hepatitis is a group of infectious diseases mainly caused by liver damage caused by a variety of different hepatitis viruses. According to etiological diagnosis, there are at least 5 types of hepatitis viruses, namely hepatitis A, B, C, D, and E Viruses that cause viral hepatitis A, B, C, D, and E respectively, namely hepatitis A (hepatitis A), hepatitis B (hepatitis B), hepatitis C (hepatitis C), and hepatitis D (hepatitis D) and hepatitis E. The other, called viral hepatitis G, is less common. Viral hepatitis is mainly transmitted through feces-oral, blood or body fluids. Clinically, fatigue, loss of appetite, hepatomegaly, and abnormal liver function are the main manifestations. Jaundice occurs in some cases, and asymptomatic infection is common. [0003] At present, for the treatment of liver...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8965A61P1/16A61P31/14A61P31/20A61K31/122A61K31/375A61K31/4168A61K33/28A61K35/62
Inventor 张强
Owner CHENGDU JIANJIANG PHARMA FACTORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap